Sagimet Biosciences Inc. (SGMT): Cash & Equivalents
$35.02M
As of 2025-12-31
$165.90M
As of 2026-06-30
n/m
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $35.02M | -53.8% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $75.84M | +0.9% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $75.14M | n/m | 2025-03-12, Balance as of period end |
| 2022-12-31 | $158.0K | n/a | 2024-03-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $35.02M | -53.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $37.98M | -7.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $47.05M | -23.7% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $109.52M | +71.0% |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $95.50M | -25.7% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $52.77M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $73.05M | +188.6% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $21.82M | -60.8% |
Compare SGMT, AVTX, PMVP, AARD side by side · Screen every company in Pharmaceutical Preparations ↗